No Data
No Data
Deciphera Pharmaceuticals: A Hold Rating Amidst Ono Pharmaceutical Acquisition Offer
Ono Pharmaceutical: Extraordinary Report
Earnings Call Summary | ONO PHARMACEUTICAL CO(OPHLF.US) Q1 2024 Earnings Conference
The following is a summary of the Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 2024 Earnings Call Transcript:Financial Performance:Ono Pharmaceutical reported Q1 revenue of ¥502.7 billion, marking their fi
Fuji HD, Rinnai, etc. (added) Rating
Upgrade-Bullish Code | Stock Name | Securities Company | Conventional | After Change |------|------------|------------|------------|---------|<9229>|SunWells |Nomura | “Neutral” | “Buy” |<9434>|SoftBank | Germany | “Hold” | “Buy” |Target Stock Price Change Code
Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]
○ List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime <1663> K&O Energy 3295 3515 <1870> Yahagi Ken 1501 1570 <1930> Hokuriku Denko 1146 1201 <1968> Taiheiden 4295 4480 <2579> Coca BJH
It is a solid development with a rise of over 70%
[Nikkei Stock Average, TOPIX (table)] Nikkei Average; 38392.10; +189.73 TOPIX; 2727.05; +20.62 [Backstage Investment Strategy] The aftermarket draws attention to financial results announced during trading hours. At 12:00, Asahi Kasei <3407>, Ono Yaku<4528>, Sumitomo Riko <5191>, Chiyoken <6366>, SMK <6798>, and at 13:00, Sumidensetsu <1949>, Daicel <4202>, Pia <4337>, Hokuetsu Engineering <6364>, Takashima <8
No Data